LEUKEMIA, T-CELL

Clinical trials for LEUKEMIA, T-CELL explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, T-CELL trials appear

Sign up with your email to follow new studies for LEUKEMIA, T-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Engineered t cells take aim at stubborn leukemias in early trial

Disease control Not yet recruiting

This early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…

Matched conditions: LEUKEMIA, T-CELL

Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC

LEUKEMIA, T-CELL

Get alerted when new LEUKEMIA, T-CELL trials appear

Engineered t cells take aim at stubborn leukemias in early trial